← Back to Search

Physical Therapy Exercise for Sickle Cell Disease (SuCCESs Trial)

N/A

Recruiting

Research Sponsored by University of Maryland, Baltimore

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Children 6-17 years of age diagnosed with sickle cell disease

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up throughout the entire study week 1, weeks 2-6, six weeks of intervention, and week 7

Awards & highlights

SuCCESs Trial Summary

This trial, called SuCCESs, will investigate if a program involving exercises that improve strength, balance, speed, and agility is possible and beneficial for children with sickle cell disease.

Who is the study for?

The SuCCESs trial is for children aged 6-17 who have been diagnosed with sickle cell disease. It's designed to see if a special exercise program can help them without causing harm.Check my eligibility

What is being tested?

This study tests a moderate intensity exercise program focused on strengthening, balance, speed, and agility in young patients with sickle cell disease to determine its safety and effectiveness.See study design

What are the potential side effects?

Since the trial involves physical exercise, potential side effects may include muscle soreness, fatigue, or pain. There might be specific risks related to sickle cell complications that will be monitored.

SuCCESs Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SuCCESs Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ throughout the entire study week 1, weeks 2-6, six weeks of intervention, and week 7

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~throughout the entire study week 1, weeks 2-6, six weeks of intervention, and week 7

This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout the entire study week 1, weeks 2-6, six weeks of intervention, and week 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of Muscle Activation

exercise tolerance

knee extension strength

+2 more

SuCCESs Trial Design

1Treatment groups

Experimental Treatment

Group I: Physical Therapy ExerciseExperimental Treatment1 Intervention

There will be no control group and only one intervention delivered

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor

688 Previous Clinical Trials

374,636 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to participate in this ongoing medical study?

"Indeed, the details provided on clinicaltrials.gov confirm that this clinical trial is actively seeking eligible participants. The study was initially posted on November 3rd, 2023 and has been recently updated on January 17th, 2024. A total of 20 patients will be enrolled in this trial across two designated sites."

Answered by AI

Can individuals such as myself participate in this clinical study?

"To qualify for participation in this clinical trial, individuals must have a confirmed diagnosis of sickle cell disease and fall within the age range of 6 to 17 years. The study aims to enroll approximately 20 eligible participants."

Answered by AI

What is the number of participants currently enrolled in this clinical study?

"Indeed, according to the information available on clinicaltrials.gov, this ongoing study is actively seeking eligible candidates. The trial was initially posted on November 3rd, 2023 and last updated on January 17th, 2024. The research team aims to recruit a total of 20 participants from two distinct sites."

Answered by AI